What does this research mean for the field?

The distinction between fibroadenomas and benign phyllodes tumors in pediatric breast fibroepithelial lesions does not impact clinical outcomes. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to characterize pediatric fibroepithelial lesions (FELs) at both molecular and clinical levels.

March 13, 2026

Clinicopathological and Molecular Characterization of Pediatric Breast Fibroepithelial Lesions: A Cohort Study.

Puntos clave

This research aims to characterize pediatric fibroepithelial lesions (FELs) at both molecular and clinical levels.
Conducted a cohort study of pediatric cases with breast fibroepithelial lesions.
Compared clinicopathological features of fibroadenomas and benign phyllodes tumors.
Analyzed the impact of lesion type on clinical outcomes.
No significant difference in clinical outcomes between fibroadenomas and benign phyllodes tumors.
Findings support the idea of a diagnostic continuum for pediatric FELs.
Prognostic significance of the distinction between FA and benign PT is limited.

Resumen

Pediatric FELs likely represent a diagnostic continuum. In this cohort, the distinction between FA and benign PT did not impact clinical outcome, suggesting limited prognostic significance.

Me gusta

Guardar

Cite This Study

Zhang et al. (Wed,) studied this question.

synapsesocial.com/papers/69b3ad0502a1e69014ccf45d https://doi.org/https://doi.org/10.1080/15513815.2026.2640505

Me gusta

Guardar